Summary
- Current Price
- As of today, IGC price is $0.27, unchanged in the most recent trading session on
- Current Price All-Time High
- IGC price is currently -99.62% below its historical high of $71.10 set on
- Market Cap
- IGC current market cap is $26M, up +13.31% over the past 365 days
- PE Ratio
- IGC PE ratio is unknown
- Revenue
- IGC current annual revenue is $1.27M, down -5.50% year-over-year
- Next Earnings
- As of today, the next earnings release for IGC has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | IGC Pharma, Inc. |
| Ticker | NYSEAmerican: IGC |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | igcpharma.com |
| Employees | 70 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.27 | ||
| Price, 1D Change | 0.00% | |
| $26M | ||
| - | ||
| - | ||
| 0.59 | ||
| $1M | ||
| Revenue, 1Y Change | -5.50% | |
| -$0.09 | ||
| EPS, 1Y Change | +57.85% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.09 | ||
| EPS Estimate | N/A | -$0.08 |
| EPS Est. Change | N/A | +14.07% |
| $1.27M | ||
| Revenue Estimate | N/A | $910.00K |
| Revenue Est. Change | N/A | -28.40% |
| $0.27 | ||
| Price Target | - | $4.00 |
| Price Tgt. Change | - | +1,381.48% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.22 | -$0.22 | -0.41% | |
| -$0.10 | -$0.09 | +6.90% | |
| -$0.08 | N/A | +14.07% | |
| -$0.09 | N/A | +3.33% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.35M | $1.35M | 0.00% | |
| $1.25M | $1.27M | +2.01% | |
| $910.00K | N/A | -28.40% | |
| $1.00M | N/A | -21.16% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -3.57% | ||
| -20.59% | ||
| +13.31% | ||
| +42.19% | ||
| -5.50% | ||
| +220.15% | ||
| +57.85% | ||
| +69.01% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.27 | ||
| $0.34 | ||
| SMA 200 vs Price | +25.00% | |
| $0.27 | ||
| SMA 50 vs Price | +1.19% | |
| 0.59 | ||
| $0.02 | ||
| 50.00 | ||
| 77.08% | ||
| 61.41% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.27M | ||
| -$0.09 | ||
| $52.00K | ||
| 4.09% | ||
| -$7.45M | ||
| -585.84% | ||
| -$7.12M | ||
| -560.27% | ||
| -$6.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 1.28 | ||
| 0.68 | ||
| - | ||
| 3 | ||
| -15.53 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 21.40 | ||
| 3.46 | ||
| -2.86 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $6.33M | ||
| $405.00K | ||
| $8.75M | ||
| $2.90M | ||
| $2.42M | ||
| $2.26M | ||
| $241.00K | ||
| $97.00K | ||
| $883.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $8.39M | ||
| $8.07M | ||
| $1.22M | ||
| $0.00 | ||
| $618.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$4.80M | ||
| -$442.00K | ||
| $4.45M | ||
| $482.00K | ||
| -$5.28M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Alliance Global Partners | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Alliance Global Partners | ||
| Ascendiant Capital | → |
Analyst sentiment
Institutional ownership
Screeners with IGC
FAQ
What is the ticker symbol for IGC Pharma, Inc.?
The ticker symbol for IGC Pharma, Inc. is NYSEAmerican:IGC
Does IGC Pharma, Inc. pay dividends?
No, IGC Pharma, Inc. does not pay dividends
What sector is IGC Pharma, Inc. in?
IGC Pharma, Inc. is in the Healthcare sector
What industry is IGC Pharma, Inc. in?
IGC Pharma, Inc. is in the Biotechnology industry
What country is IGC Pharma, Inc. based in?
IGC Pharma, Inc. is headquartered in United States
When did IGC Pharma, Inc. go public?
IGC Pharma, Inc. initial public offering (IPO) was on May 24, 2006
Is IGC Pharma, Inc. in the S&P 500?
No, IGC Pharma, Inc. is not included in the S&P 500 index
Is IGC Pharma, Inc. in the NASDAQ 100?
No, IGC Pharma, Inc. is not included in the NASDAQ 100 index
Is IGC Pharma, Inc. in the Dow Jones?
No, IGC Pharma, Inc. is not included in the Dow Jones index
When was IGC Pharma, Inc. last earnings report?
IGC Pharma, Inc.'s most recent earnings report was on November 4, 2022
When does IGC Pharma, Inc. report earnings?
The date for IGC Pharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- IGC Official Website igcpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1326205/000118518525000706/0001185185-25-000706-index.htm
- IGC Profile on Yahoo Finance finance.yahoo.com/quote/IGC
- IGC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/igc
